Selected research
Market Structure
Global Pharmaceutical Grade Melatonin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Pharmaceutical Grade Melatonin market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Pharmaceutical Grade Melatonin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Pharmaceutical Grade Melatonin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Pharmaceutical Grade Melatonin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Pharmaceutical Grade Melatonin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Pharmaceutical Grade Melatonin include Teva, Mylan, Pharma Nord, Neurim Pharmaceuticals, Flynn Pharma, Aspen Pharmacare, Alturix and AGB-Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Pharmaceutical Grade Melatonin market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Pharmaceutical Grade Melatonin and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Pharmaceutical Grade Melatonin sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pharmaceutical Grade Melatonin market size, projected growth trends, production technologies, key applications, and end-use industries.
Pharmaceutical Grade Melatonin Segment by Company
Teva
Mylan
Pharma Nord
Neurim Pharmaceuticals
Flynn Pharma
Aspen Pharmacare
Alturix
AGB-Pharma
Pharmaceutical Grade Melatonin Segment by Type
Tablets
Oral Solution
Pharmaceutical Grade Melatonin Segment by Application
Hospital and Clinic
Pharmacy
Other
Pharmaceutical Grade Melatonin Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Grade Melatonin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Grade Melatonin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Grade Melatonin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Pharmaceutical Grade Melatonin market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pharmaceutical Grade Melatonin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Pharmaceutical Grade Melatonin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Pharmaceutical Grade Melatonin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Tablets
- Oral Solution
Applications
- Hospital and Clinic
- Pharmacy
- Other
Companies covered
- Teva
- Mylan
- Pharma Nord
- Neurim Pharmaceuticals
- Flynn Pharma
- Aspen Pharmacare
- Alturix
- AGB-Pharma
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Pharmaceutical Grade Melatonin Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Pharmaceutical Grade Melatonin Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Pharmaceutical Grade Melatonin Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Pharmaceutical Grade Melatonin Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Pharmaceutical Grade Melatonin Market Dynamics
- 2.1 Pharmaceutical Grade Melatonin Industry Trends
- 2.2 Pharmaceutical Grade Melatonin Industry Drivers
- 2.3 Pharmaceutical Grade Melatonin Industry Opportunities and Challenges
- 2.4 Pharmaceutical Grade Melatonin Industry Restraints
3 Pharmaceutical Grade Melatonin Market by Manufacturers
- 3.1 Global Pharmaceutical Grade Melatonin Revenue by Manufacturers (2021-2026)
- 3.2 Global Pharmaceutical Grade Melatonin Sales by Manufacturers (2021-2026)
- 3.3 Global Pharmaceutical Grade Melatonin Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Pharmaceutical Grade Melatonin Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Pharmaceutical Grade Melatonin Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Pharmaceutical Grade Melatonin Manufacturers, Product Type & Application
- 3.7 Global Pharmaceutical Grade Melatonin Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Pharmaceutical Grade Melatonin Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Pharmaceutical Grade Melatonin Players Market Share by Revenue in 2025
- 3.8.3 2025 Pharmaceutical Grade Melatonin Tier 1, Tier 2, and Tier 3
4 Pharmaceutical Grade Melatonin Market by Type
- 4.1 Pharmaceutical Grade Melatonin Type Introduction
- 4.1.1 Tablets
- 4.1.2 Oral Solution
- 4.2 Global Pharmaceutical Grade Melatonin Sales by Type
- 4.2.1 Global Pharmaceutical Grade Melatonin Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Pharmaceutical Grade Melatonin Sales by Type (2021-2032)
- 4.2.3 Global Pharmaceutical Grade Melatonin Sales Market Share by Type (2021-2032)
- 4.3 Global Pharmaceutical Grade Melatonin Revenue by Type
- 4.3.1 Global Pharmaceutical Grade Melatonin Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Pharmaceutical Grade Melatonin Revenue by Type (2021-2032)
- 4.3.3 Global Pharmaceutical Grade Melatonin Revenue Market Share by Type (2021-2032)
5 Pharmaceutical Grade Melatonin Market by Application
- 5.1 Pharmaceutical Grade Melatonin Application Introduction
- 5.1.1 Hospital and Clinic
- 5.1.2 Pharmacy
- 5.1.3 Other
- 5.2 Global Pharmaceutical Grade Melatonin Sales by Application
- 5.2.1 Global Pharmaceutical Grade Melatonin Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Pharmaceutical Grade Melatonin Sales by Application (2021-2032)
- 5.2.3 Global Pharmaceutical Grade Melatonin Sales Market Share by Application (2021-2032)
- 5.3 Global Pharmaceutical Grade Melatonin Revenue by Application
- 5.3.1 Global Pharmaceutical Grade Melatonin Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Pharmaceutical Grade Melatonin Revenue by Application (2021-2032)
- 5.3.3 Global Pharmaceutical Grade Melatonin Revenue Market Share by Application (2021-2032)
6 Global Pharmaceutical Grade Melatonin Sales by Region
- 6.1 Global Pharmaceutical Grade Melatonin Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Pharmaceutical Grade Melatonin Sales by Region (2021-2032)
- 6.2.1 Global Pharmaceutical Grade Melatonin Sales by Region (2021-2026)
- 6.2.2 Global Pharmaceutical Grade Melatonin Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Pharmaceutical Grade Melatonin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Pharmaceutical Grade Melatonin Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Pharmaceutical Grade Melatonin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Pharmaceutical Grade Melatonin Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Pharmaceutical Grade Melatonin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Pharmaceutical Grade Melatonin Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Pharmaceutical Grade Melatonin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Pharmaceutical Grade Melatonin Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Pharmaceutical Grade Melatonin Revenue by Region
- 7.1 Global Pharmaceutical Grade Melatonin Revenue by Region
- 7.1.1 Global Pharmaceutical Grade Melatonin Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Pharmaceutical Grade Melatonin Revenue by Region (2021-2026)
- 7.1.3 Global Pharmaceutical Grade Melatonin Revenue by Region (2027-2032)
- 7.1.4 Global Pharmaceutical Grade Melatonin Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Pharmaceutical Grade Melatonin Revenue (2021-2032)
- 7.2.2 North America Pharmaceutical Grade Melatonin Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Pharmaceutical Grade Melatonin Revenue (2021-2032)
- 7.3.2 Europe Pharmaceutical Grade Melatonin Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Pharmaceutical Grade Melatonin Revenue (2021-2032)
- 7.4.2 Asia-Pacific Pharmaceutical Grade Melatonin Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Pharmaceutical Grade Melatonin Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Pharmaceutical Grade Melatonin Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Teva
- 8.1.1 Teva Company Information
- 8.1.2 Teva Business Overview
- 8.1.3 Teva Pharmaceutical Grade Melatonin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Teva Pharmaceutical Grade Melatonin Product Portfolio
- 8.1.5 Teva Recent Developments
- 8.2 Mylan
- 8.2.1 Mylan Company Information
- 8.2.2 Mylan Business Overview
- 8.2.3 Mylan Pharmaceutical Grade Melatonin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Mylan Pharmaceutical Grade Melatonin Product Portfolio
- 8.2.5 Mylan Recent Developments
- 8.3 Pharma Nord
- 8.3.1 Pharma Nord Company Information
- 8.3.2 Pharma Nord Business Overview
- 8.3.3 Pharma Nord Pharmaceutical Grade Melatonin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Pharma Nord Pharmaceutical Grade Melatonin Product Portfolio
- 8.3.5 Pharma Nord Recent Developments
- 8.4 Neurim Pharmaceuticals
- 8.4.1 Neurim Pharmaceuticals Company Information
- 8.4.2 Neurim Pharmaceuticals Business Overview
- 8.4.3 Neurim Pharmaceuticals Pharmaceutical Grade Melatonin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Neurim Pharmaceuticals Pharmaceutical Grade Melatonin Product Portfolio
- 8.4.5 Neurim Pharmaceuticals Recent Developments
- 8.5 Flynn Pharma
- 8.5.1 Flynn Pharma Company Information
- 8.5.2 Flynn Pharma Business Overview
- 8.5.3 Flynn Pharma Pharmaceutical Grade Melatonin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Flynn Pharma Pharmaceutical Grade Melatonin Product Portfolio
- 8.5.5 Flynn Pharma Recent Developments
- 8.6 Aspen Pharmacare
- 8.6.1 Aspen Pharmacare Company Information
- 8.6.2 Aspen Pharmacare Business Overview
- 8.6.3 Aspen Pharmacare Pharmaceutical Grade Melatonin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Aspen Pharmacare Pharmaceutical Grade Melatonin Product Portfolio
- 8.6.5 Aspen Pharmacare Recent Developments
- 8.7 Alturix
- 8.7.1 Alturix Company Information
- 8.7.2 Alturix Business Overview
- 8.7.3 Alturix Pharmaceutical Grade Melatonin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Alturix Pharmaceutical Grade Melatonin Product Portfolio
- 8.7.5 Alturix Recent Developments
- 8.8 AGB-Pharma
- 8.8.1 AGB-Pharma Company Information
- 8.8.2 AGB-Pharma Business Overview
- 8.8.3 AGB-Pharma Pharmaceutical Grade Melatonin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 AGB-Pharma Pharmaceutical Grade Melatonin Product Portfolio
- 8.8.5 AGB-Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Pharmaceutical Grade Melatonin Value Chain Analysis
- 9.1.1 Pharmaceutical Grade Melatonin Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Pharmaceutical Grade Melatonin Production Mode & Process
- 9.2 Pharmaceutical Grade Melatonin Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Pharmaceutical Grade Melatonin Distributors
- 9.2.3 Pharmaceutical Grade Melatonin Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst